Disruptive Mood Dysregulation Disorder (DMDD)

Chronic Irritability and Severe Temper Outbursts in Children

Disruptive Mood Dysregulation Disorder (DMDD) is a DSM-5 diagnosis introduced in 2013 to address what had become a pediatric over-diagnosis crisis: large numbers of children with chronic irritability and severe temper outbursts were being labeled as bipolar disorder despite not having clear manic episodes. DMDD provided an alternative diagnostic home for these children — chronic, severe non-episodic irritability — and reduced inappropriate bipolar diagnosis. The disorder applies to children ages 6 to 18, with onset before age 10.

Key Facts

  • Prevalence: 2–5% of children
  • Symptoms must be present before age 10
  • Diagnosis only made between ages 6 and 18
  • Created to reduce pediatric bipolar over-diagnosis
  • Children with DMDD typically develop unipolar depression and anxiety, not bipolar disorder, in adulthood
  • Limited treatment evidence base; approaches drawn from related disorders

DSM-5 Diagnostic Criteria

DMDD (296.99 / F34.81) requires:

  1. Severe recurrent temper outbursts manifested verbally and/or behaviorally that are grossly out of proportion to the situation or provocation
  2. Outbursts inconsistent with developmental level
  3. Outbursts occur, on average, three or more times per week
  4. Mood between outbursts is persistently irritable or angry most of the day, nearly every day, observable by others
  5. Criteria 1–4 present for ≥12 months, with no symptom-free period of ≥3 consecutive months
  6. Criteria 1 and 4 present in at least two of three settings (home, school, peers)
  7. Diagnosis only made between ages 6 and 18
  8. Onset before age 10
  9. Has never been a distinct period (1+ day) meeting full criteria for hypomanic or manic episode
  10. Not better explained by another disorder

Why DMDD Was Created

  • Between 1994 and 2003, U.S. pediatric bipolar diagnosis increased ~40-fold
  • Most diagnosed children had chronic irritability rather than discrete manic episodes
  • Long-term studies showed these children developed depression and anxiety, not bipolar disorder
  • DMDD provided an alternative diagnosis to capture these presentations without inappropriately committing children to lifelong bipolar treatment regimens

DMDD vs. Bipolar vs. ODD

  • Pediatric bipolar: Discrete episodes of mania or hypomania (decreased need for sleep, grandiosity, racing thoughts, increased goal-directed activity); rare in prepubertal children
  • DMDD: Chronic baseline irritability between outbursts — no episode pattern
  • ODD: Argumentative and defiant behavior; DMDD requires more severe outbursts AND chronic irritability between them. Both cannot be diagnosed simultaneously — DMDD takes precedence if criteria are met
  • Major depression: Can co-occur; mood quality differs (depressed vs. irritable)

Course and Outcomes

  • Symptoms typically begin in early childhood
  • Some improvement common by adolescence
  • Adult outcomes: most develop unipolar depression and anxiety; bipolar disorder is uncommon
  • Comorbidity with ADHD, ODD, and anxiety is the rule
  • Functional impairment in school and family typically severe

Treatment

The DMDD diagnosis is recent and the evidence base is still developing. Treatment draws from approaches for related conditions:

Therapy

  • Parent management training (PCIT, The Incredible Years)
  • CBT adapted for irritability
  • Dialectical Behavior Therapy for Children (DBT-C)
  • Interpretation Bias Training emerging

Medication

  • Stimulants for comorbid ADHD often help broadly
  • SSRIs for comorbid depression and anxiety
  • Atypical antipsychotics (risperidone, aripiprazole) sometimes used for severe aggression — use with caution given side effects
  • Mood stabilizers generally not first-line for DMDD (unlike pediatric bipolar)

School and Family Support

  • Behavioral plans across settings
  • Family work to reduce coercive interaction patterns
  • Consistent structure and predictability

Conclusion

DMDD reflects a deliberate attempt by DSM-5 to correct a pediatric over-diagnosis problem and to give clinicians a more accurate diagnostic home for chronic, severely irritable children. The change has had measurable effects, reducing inappropriate bipolar diagnosis. The downside is that the new diagnosis arrived without an established treatment evidence base, leaving clinicians to extrapolate from related conditions. Research is still establishing what works best.

Related Topics